The Human Immunodeficiency Virus Type-1 (HIV-1) Tat Protein and Bcl-2 Gene Expression

References

• Jones K. A., Peterlin M. B. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 1994; 63: 717–743
   PubMed Web of Science ®Google Scholar
• Ranki A., Lagerstedt A., Ovod V., Aavik E., Krohn K. J. E. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 1994; 139: 365–378
   PubMed Web of Science ®Google Scholar
• Laspia M. F., Rice A. P., Mathew M. B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 1989; 59: 283–292
   PubMed Web of Science ®Google Scholar
• Marciniak R. A., Calnan B. J., Frankel A. D., Sharp P. A. HIV-1 Tat protein trans-activates transcription in vitro. Cell 1990; 63: 791–802
   PubMed Web of Science ®Google Scholar
• Cullen B. R. Does HIV-1 tat induce a change in viral initiation rights?. Cell 1993; 73: 417–419
   PubMed Web of Science ®Google Scholar
• Koken S. E. C., Greijer A. E., Verhoef K., Van Wamel J., Bukrinskaya A. G., Berkout B. Intracellular analysis of in vitro modified HIV Tat protein. J. Biol. Chem. 1994; 269: 8366–8374
   PubMed Web of Science ®Google Scholar
• Dang C. V., Lee W. M. F. Nuclear and nucleolar targeting sequences of c-erb-A, c-myc, N-myc, p53, HPS70, and HIV tat proteins. J. Biol. Chem. 1989; 264: 18019–18023
   PubMed Web of Science ®Google Scholar
• Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A., Valerio R. HIV-1 tat protein binds transactivation-response region (TAR) in vitro. Proc. Natl. Acad. Sci. USA 1989; 86: 6925–6932
   PubMed Web of Science ®Google Scholar
• Taylor J. P., Kunda M., Khalili K. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. Virol. 1993; 195: 780–788
   PubMed Web of Science ®Google Scholar
• Huang L., Joshi A., Willey R., Orenstein J., Jeang K. T. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 1994; 13: 2886–2893
   PubMed Web of Science ®Google Scholar
• Ensoli B., Barillari G., Zaki Salahuddin S., Gallo R. C., Wong-Stall F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990; 345: 84–86
   PubMed Web of Science ®Google Scholar
• Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type I tat protein on cell growth and viral transactivation. J. Virol. 1993; 67: 277–287
   PubMed Web of Science ®Google Scholar
• Milani D., Zauli G., Neri L. M., Marchisio M., Previati M., Capitani S. Influence of the human immunodeficiency virus type 1 tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J. Gen. Virol. 1993; 74: 2587–2594
   PubMed Web of Science ®Google Scholar
• Frankel A. D., Pabo C. O. Cellular uptake of the Tat protein from Human immunodeficiency virus. Cell 1988; 55: 1189–1193
   PubMed Web of Science ®Google Scholar
• Mann D. A., Frankel A. D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 1991; 10: 1733–1739
   PubMed Web of Science ®Google Scholar
• Bonifaci N., Sitia R., Rubartelli A. Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS 1995; 9: 995–1000
   PubMed Web of Science ®Google Scholar
• Fawell S., Seery J., Daikh Y., Moore C., Chen L. L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 1994; 91: 664–671
   PubMed Web of Science ®Google Scholar
• Nigg E. A., Baeuerle P. A., Luhrmann R. Nuclear-import-export: in search of signals and mechanisms. Cell 1991; 66: 15–22
   PubMed Web of Science ®Google Scholar
• Marasco W. A., Szilvay A. M., Kalland K. H., Helland D. G., Reyes H. M., Walter R. J. Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably trans-fected Jurkat T-cells. Arch. Virol. 1994; 139: 133–154
   PubMed Web of Science ®Google Scholar
• Paine P. L., Moore L. C., Horowitz S. B. Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors. J. Cell Biol. 1990; I11: 807–816
   Google Scholar
• Olsnes S., Moskaug J. O., Stenmark H., Sandvig K. Diphtheria toxin entry: protein translocation in the reverse direction. Trends Biochem. Sci. 1988; 13: 348–351
   PubMed Web of Science ®Google Scholar
• Abraham J. A., Mergia A., Whang J. L., Tumolo A., Friedman J., Hjerrild K. A., Gospodarowicz D., Fiddes J. C. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 1986; 233: 545–548
   PubMed Web of Science ®Google Scholar
• Rusnati M., Coltrini D., Caccia P., Dell'Era P., Zoppetti G., Oreste P., Valsasina B., Presta M. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. Biochem. Biophis. Res. Commu. 1994; 203: 250–258
   Google Scholar
• Brake D. A., Debouck C., Biesecher G. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J. Cell Biol. 1990; 111: 1275–1281
   PubMed Web of Science ®Google Scholar
• Barillari G., Gendelman R., Gallo R. C., Ensoli B. The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same types by using integrin receptors recognizing RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 1993; 90: 7941–7945
   PubMed Web of Science ®Google Scholar
• Vogel B. E., Lee S. J., Hildebrand A., Craig W., Pierschbacher M. D., Wong-Staal F., Ruoslahti E. A novel integrin specificify exemplified by binding of the α,β5 integrin to the basic domain of the HIV tat protein and vitronectin. J. Cell Biol. 1993; 121: 461–468
   PubMed Web of Science ®Google Scholar
• Weeks B. S., Desai K., Loewenstein P. M., Klotman M. E., Klotman P., Green M., Kleinman H. K. Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J. Biol. Chem. 1993; 268: 5279–5284
   PubMed Web of Science ®Google Scholar
• Albini A., Fontanini G., Masiello L., Tacchetti C., Bigini D., Luzzi P., Noonan D. M., Stetler-Stevenson W. G. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 1994; 8: 1237–1244
   PubMed Web of Science ®Google Scholar
• Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M., Cafaro A., Chang H. K., Brady J. N., Gallo R. C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994; 371: 674–680
   PubMed Web of Science ®Google Scholar
• Kim C. M., Vogel J., Jay G., Rhim J. S. The HIV tat gene transforms human keratinocytes. Oncogene 1992; 7: 1525–1529
   PubMed Web of Science ®Google Scholar
• Zauli G., Gibellini D., Milani D., Mazzoni M., Borgatti P., La Placa M., Capitani S. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 1993; 53: 4481–4485
   PubMed Web of Science ®Google Scholar
• Caputo A., Sodroski J. G., Haseltine W. A. Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. J. AIDS 1990; 3: 372–379
   PubMed Web of Science ®Google Scholar
• Zauli G., Marchisio M., Bertagnolo V., Celeghini C., Capitani S. HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat phechromocytoma cell line. Oncology Reports 1994; 1: 773–777
   PubMed Web of Science ®Google Scholar
• Fauci A. S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993; 262: 1011–1018
   PubMed Web of Science ®Google Scholar
• Gibellini D., Caputo A., Celeghini C., Bassini A., La Placa M., Capitani S., Zauli G. Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br. J. Haematol. 1995; 89: 24–33
   PubMed Web of Science ®Google Scholar
• Zauli G., Gibellini D., Caputo A., Bassini A., Negrini M., Monne M., Mazzoni M., Capitani S. The human immunodeficiency virus type-1 (HIV-1) Tat protein upregulates Bcl-2 gene expression in Jurkat T cell lines and primary peripheral blood mononuclear cells. Blood 1995; 86: 3823–3834
   PubMed Web of Science ®Google Scholar
• Vogel J., Hinrichs S. H., Reynolds R. K., Luciw P. A., Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988; 335: 606–611
   PubMed Web of Science ®Google Scholar
• Vogel J., Hinrichs S. H., Napolitano L. A., Ngo L., Jay G. Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res. 1991; 51: 6686–6690
   PubMed Web of Science ®Google Scholar
• Vellutini C., Horschowski N., Philippon V., Gambarelli D., Nave K. A., Filippi P. Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res. Hu. Retro. 1995; 11: 21–29
   PubMed Web of Science ®Google Scholar
• Corallini A., Altavilla G., Pozzi L., Bignozzi F., Negrini M., Rimessi P., Gualandi F., Barbanti-Brodano G. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different hystotypes. Cancer Res. 1993; 53: 5569–5576
   PubMed Web of Science ®Google Scholar
• Harnly M. E., Swan S. H., Holly E. A., Kelter A., Padian N. Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS). Am. J. Epidemiol. 1988; 128: 261–274
   PubMed Web of Science ®Google Scholar
• Viscidi R. P., Mayur K., Lederman H. M., Frankel A. D. Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 1989; 246: 1606–1608
   PubMed Web of Science ®Google Scholar
• Subramanyam M., Gutheil W. G., Bachovchin W. W., Huber B. T. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 1993; 150: 2544–2553
   PubMed Web of Science ®Google Scholar
• Chirmule N., Than S., Khan S., Pahwa S. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J. Virol. 1995; 69: 492–498
   PubMed Web of Science ®Google Scholar
• Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M., Krammer P. H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497–500
   PubMed Web of Science ®Google Scholar
• Li C. J., Friedman D. J., Wang C., Metelev V., Pardee A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995; 268: 229–231
   Web of Science ®Google Scholar
• Purvis S. F., Jacobberger J. W., Sramkoski R. M., Patki A. H., Lederman M. M. HIV type 1 Tat protein induces apopotosis and death in Jurkat cells. AIDS Res. Hu. Retro. 1995; 11: 443–451
   PubMed Web of Science ®Google Scholar
• Philippon V., Vellutini C., Gambarelli D., Harkiss G., Arbuthnott G., Metzger D., Roubin R., Filippi P. The basic domain of the lentiviral Tal protein is responsible for damages in mouse brain: involvment of cytokines. Virology 1994; 205: 519–529
   PubMed Web of Science ®Google Scholar
• Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M., Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 1995; 37: 373–380
   PubMed Web of Science ®Google Scholar
• Zauli G., La Placa M., Vignoli M., Re M. C., Gibellini D., Furlini G., Milani D., Marchisio M., Mazzoni M., Capitani S. An autocrine loop of HIV type 1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J. AIDS 1995; 10: 306–316
   Web of Science ®Google Scholar
• Meyaard L., Otto S. A., Schuitemaker H., Miedema F. Effects of HIV-1 Tat protein on human T cell proliferation. Eur. J. Immunol. 1992; 22: 2729–2736
   PubMed Web of Science ®Google Scholar
• Buonaguro L., Buonaguro F. M., Giraldo G., Ensoli B. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 1994; 68: 2677–2682
   PubMed Web of Science ®Google Scholar
• Sastry K. J., Reddy H. R., Pandita R., Tolpal K., Aggarwal B. B. HIV-1 tat induces tumor necrosis factor-beta (lymphotoxin) in a human B lymphoblastoid cell line. J. Biol. Chem. 1990; 265: 20091–20093
   PubMed Web of Science ®Google Scholar
• Buonaguro L., Barillari G., Chang H. K., Bohan C. A., Kao V., Morgan R., Gallo R. C., Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokine. J. Virol. 1992; 66: 7159–7167
   PubMed Web of Science ®Google Scholar
• Sharma V., Knobloch T. J., Benjamin D. Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines. Biochem. Biophys. Res. Commu. 1995; 208: 704–713
   PubMed Web of Science ®Google Scholar
• Biswas D. K., Salas T. R., Wang F., Ahlers C. M., Dezube B. J., Pardee A. B. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol. 1995; 69: 7437–7444
   PubMed Web of Science ®Google Scholar
• Scala G., Ruocco M. R., Ambrosino C., Mallardo M., Giordano V., Baldassarre F., Dragonetti E., Quinto I., Venuta S. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 tat protein. J. Exp. Med. 1994; 179: 961–971
   PubMed Web of Science ®Google Scholar
• Puri R. K., Aggarwal B. B. Human immunodeficiency virus type 1 tat gene up-regulates interleukin-4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 1992; 52: 3787–3790
   PubMed Web of Science ®Google Scholar
• Gibellini D., Zauli G., Re M. C., Milani D., Furlini G., Caramelli E., Capitani S., La Placa M. Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially upregulates IL-6 and TGF-β1 mRNA expression and protein synthesis in peripheral blood monocytes. Br. J. Haematol. 1994; 88: 261–267
   PubMed Web of Science ®Google Scholar
• Zauli G., Davis B. R., Re M. C., Visani G., Furlini G., La Placa M. Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for HIV-1 induced hematopoietic suppression. Blood. 1992; 80: 3036–3043
   PubMed Web of Science ®Google Scholar
• Cupp C., Taylor P., Khalili K., Amini S. Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 1993; 8: 2231–2236
   PubMed Web of Science ®Google Scholar
• Lotz M., Clark-Lewis I., Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGFβ expression in human articular chondrocytes. J. Biol. Chem. 1994; 124: 365–371
   Google Scholar
• Westendorp M. O., Li-Weber M., Frank R. W., Krammer P. H. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 1994; 68: 4177–4185
   PubMed Web of Science ®Google Scholar
• Purvis S. F., Georges D. L., Williams T. M., Lederman M. M. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell. Immunol. 1992; 144: 32–42
   PubMed Web of Science ®Google Scholar
• Puri R. K., Leland P., Aggarwal B. B. Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoblastoid (H9) cell line. AIDS Res. Hu. Retro. 1995; 11: 31–40
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Bcl-2: a repressor of lymphocyte death. Immunol. Today 1992; 13: 285–290
   PubMedGoogle Scholar
• Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homology, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–618
   PubMed Web of Science ®Google Scholar
• Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J. A., Reed J. C. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279–288
   PubMed Web of Science ®Google Scholar
• Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B., Korsmeyer S. J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285–293
   PubMed Web of Science ®Google Scholar
• Merino R., Ding L., Veis D. J., Korsmeyer S. J., Nunez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 1994; 13: 683–692
   PubMed Web of Science ®Google Scholar
• Caputo A., Grossi M. P., Bozzini R., Rossi C., Betti M., Marconi P. C., Barbanti-Brodano G., Balboni P. G. Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region. Gene Therapy 1996; 3: 235–245
   PubMed Web of Science ®Google Scholar
• Longo F., Marchetti M. A., Castagnoli L., Battaglia P. A., Gigliani F. A novel approach to protein-protein interaction: complex formation between p53 tumor suppressor and the HIV Tat proteins. Biochem. Biophys. Res. Commu. 1995; 206: 326–334
   PubMed Web of Science ®Google Scholar
• Li C. J., Wang C., Friedman D. J., Pardee A. B. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1995; 92: 5461–5464
   PubMed Web of Science ®Google Scholar
• Flores S. C., Marecki J. C., Harper K. P., Bose S. K., Nelson S. K., Mc Cord J. M. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in Hela cells. Proc. Natl. Acad. Sci. USA 1993; 90: 7632–7636
   PubMed Web of Science ®Google Scholar
• Ursini M. V., Lettieri T., Braddock M., Martini G. Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat. Virol. 1993; 196: 338–343
   PubMed Web of Science ®Google Scholar
• Church S. L., Grant J. M., Ridnour L. A., Oberley L. W., Swanson P. E., Meltzer P. S., Trent J. M. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 3113–3117
   PubMed Web of Science ®Google Scholar
• Nabel G., Baltimore D. An inducible transcription factor activates expression of human immmunodeficiency virus in T-cell. Nature 1987; 326: 711–713
   PubMed Web of Science ®Google Scholar
• Roulston A., Lin R., Beauparlant P., Wainberg M. A., Hiscott J. Regulation of human immunodeficiency virus type-1 and cytokine gene expression in myeloid cells by NF-kB/Rel transcription factors. Microbiol. Rev. 1995; 59: 481–505
   PubMedGoogle Scholar
• AlcamÌ J., Lain De Lera T., Folgueira L., Pedraza M. A., Jacque J. M., Bachelerie F., Noriega A. R., Hay R. T., Harrich D., Gaynor R. B., Virelizier J. L., Arenzana-Seisdedos F. Absolute dependence of kB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 1995; 14: 1552–1560
   PubMed Web of Science ®Google Scholar
• Demarchi F., D'Agaro P., Falaschi A., Giacca M. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 1993; 67: 7450–7460
   PubMed Web of Science ®Google Scholar
• Westendorp M. O., Shatrov V. A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P. H., Droge W., Lehmann V. HIV-1 Tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state. EMBO (Eur. Mol. Biol. Organ.) J. 1995; 14: 546–556
   PubMed Web of Science ®Google Scholar
• Campioni D., Corallini A., Zauli G., Possati L., Altavilla G., Barbanti-Brodano G. HIV-1 type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res. Hu. Retro. 1995; 1039–1048
   PubMed Web of Science ®Google Scholar
• Steinaa L., Serensen A. M., Nielsen J. O., Hansen J. E. S. Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch. Virol. 1994; 139: 263–271
   PubMed Web of Science ®Google Scholar
• Re M. C., Furlini G., Vignoli M., Ramazzotti E., Roderigo G., De Rosa V., Zauli G., Lolli S., Capitani S., La Placa M. Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J. AIDS 1995; 10: 408–416
   Web of Science ®Google Scholar
• Krone W. J., Debouck C., Epstein L. G., Heutink P., Meloen R., Goudsmit J. Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo. J. Med. Virol. 1988; 26: 261–274
   PubMed Web of Science ®Google Scholar
• Rodman T. C., Pruslin F. H., To S. E., Winston R. Human immunodeficiency virus (HIV) tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope. J. Exp. Med. 1992; 175: 1247
   PubMedGoogle Scholar
• Zhang Z., Vuori K., Reed J. C., Ruoslahti E. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA 1995; 92: 6161–6170
   PubMed Web of Science ®Google Scholar
• Yamada A., Nikaido T., Nojima Y., Schlossman S. F., Marimoto C. Activation of Human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J. Immunol. 1991; 146: 53–62
   PubMed Web of Science ®Google Scholar
• Juliano R. L., Varner J. A. Adhesion molecules in cancer: the role of integrins. Curr. Op. Biol. 1993; 5: 812–819
   PubMed Web of Science ®Google Scholar
• Sandstrom P. A., Pardi D., Goldsmith C. S., Diamond M., Folks T. M. (1978) Bcl-2 expression facilitates HIV-1-mediated cytopathic effects during acute spreading infections. 3rd Conference on Retroviruses and Opportunistic Infections, Abs. 1996; 92, Washington, DC, January 28-February 1, 1996
   Google Scholar
• Herndier B. G., Kaplan L. D., McGrath M. S. Pathogenesis of AIDS lymphomas. AIDS 1994; 8: 1025–1044
   PubMed Web of Science ®Google Scholar
• Hockenbery D. M., Zutter M., Hickey W., Nahm M., Korsmeyer S. J. Bcl-2 protein is topographically restricted in tissues characterized by apopototic cell death. Proc. Natl. Acad. Sci. USA 1991; 88: 6961–6965
   PubMed Web of Science ®Google Scholar
• Akbar A. N., Borthwick N., Salmon M., Gombert W., Bofill M., Shamsadeen N., Pilling D., Pett S., Grundy J. E., Janossy G. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J. Exp. Med., 178: 427–438
   PubMed Web of Science ®Google Scholar